Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
2,74 USD | -8,05 % | -6,80 % | +73,42 % |
Métier
Nombre d'employés: 37
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Novel Bispecific Antibodies
100,0
%
| 20 | 100,0 % | 7 | 100,0 % | -64,09 % |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Netherlands
100,0
%
| 20 | 100,0 % | 7 | 100,0 % | -64,09 % |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 56 | 01/06/19 | |
Fred M. Powell
DFI | Director of Finance/CFO | 63 | 01/11/22 |
Chief Tech/Sci/R&D Officer | - | 09/11/21 | |
Chief Tech/Sci/R&D Officer | 50 | 01/01/17 | |
Chief Tech/Sci/R&D Officer | 59 | 06/02/23 | |
Chief Tech/Sci/R&D Officer | 60 | 01/05/18 | |
Robin Hume
LAW | General Counsel | - | 15/05/23 |
Human Resources Officer | - | 09/11/21 | |
Amy Garabedian
LAW | General Counsel | - | 27/07/21 |
Peter Ros
PRN | Corporate Officer/Principal | 52 | 01/01/20 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 56 | 01/06/19 | |
Karen Wilson
BRD | Director/Board Member | 61 | 01/04/21 |
James Noble
BRD | Director/Board Member | 65 | 15/06/22 |
Peter Kiener
BRD | Director/Board Member | 72 | 01/01/23 |
Jay Backstrom
BRD | Director/Board Member | 69 | 15/06/22 |
Kapil Dhingra
CHM | Chairman | 64 | 22/02/21 |
Mary Wadlinger
BRD | Director/Board Member | 64 | 01/01/23 |
Christy Oliger
BRD | Director/Board Member | 54 | 09/03/23 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 26 289 087 | 18 738 315 ( 71,28 %) | 0 | 71,28 % |
Coordonnées société
Secteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+73,42 % | 72,03 M | |
+4,09 % | 43,84 Md | |
+9,45 % | 41,68 Md | |
+46,00 % | 41,25 Md | |
-10,92 % | 27,04 Md | |
+9,32 % | 25,53 Md | |
-24,87 % | 18,18 Md | |
+1,28 % | 12,29 Md | |
+29,70 % | 12,29 Md | |
+7,78 % | 11,15 Md |
- Bourse
- Actions
- Action LVTX
- Société LAVA Therapeutics N.V.